Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (46)

« Back to Publications

Nasopharyngeal Microbiome Composition and its Clinical Correlates in Children Hospitalized with Severe Pneumonia in East Africa.

Makori TO. et al, (2026), J Infect Dis

Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020-2025): Clinical Features and Wave Patterns.

Lambisia AW. et al, (2026), Open Forum Infect Dis, 13

Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia.

Njunge JM. et al, (2025), Nat Commun, 16

Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia

Njunge J. et al, (2025)

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.

Terstappen J. et al, (2024), Lancet Infect Dis, 24, e747 - e761

New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023.

Mwanga MJ. et al, (2023), Emerg Infect Dis, 29, 2376 - 2379

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults.

Green C. et al, (2023), Clin Exp Immunol, 211, 269 - 279

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.

Mazur NI. et al, (2023), Lancet Infect Dis, 23, e2 - e21

A new Omicron lineage with Spike Y451H mutation that dominated a new COVID-19 wave in Kilifi, Coastal Kenya: March-May 2023

Mwanga M. et al, (2023)

Development of a controlled human infection model to study respiratory syncytial virus infection in older adults.

Sande CJ., (2022), Lancet Healthy Longev, 3, e370 - e371

Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries.

Carbonell-Estrany X. et al, (2022), Front Pediatr, 10

Implementation strategies for passive respiratory syncytial virus immunisation.

Sande CJ., (2021), Lancet Infect Dis, 21, 1200 - 1201

Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013.

Zylbersztejn A. et al, (2021), Euro Surveill, 26

Enrichment approach for unbiased sequencing of respiratory syncytial virus directly from clinical samples.

Waweru JW. et al, (2021), Wellcome Open Res, 6

Enrichment approach for unbiased sequencing of respiratory syncytial virus directly from clinical samples.

Waweru JW. et al, (2021), Wellcome open research, 6

Load More